Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Steroid tapering schedules after liver transplantation for recurrent hepatitis C fibrosis
2008-002295-10Phase 3Completed
- Sponsor
- Sant'Orsola-Malpighi University Hospital
- Start
- Jun 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prednisone and tacrolimus in hepatitis C virus infection and hepatic fibrosis (2 arms), sponsored by Sant'Orsola-Malpighi University Hospital. Started Jun 2008; status: completed.
02
Drugs
prednisonetacrolimus
03
Conditions
hepatitis C virus infectionhepatic fibrosis
Beyond the preview
Go deeper on 2008-002295-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-002295-10.